Advanced Search

Technical Analysis for VIE - Viela Bio, Inc.

Grade Last Price % Change Price Change
grade B 44.46 -0.78% -0.35
VIE closed down 0.78 percent on Friday, February 21, 2020, on 20 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical VIE trend table...
Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish -0.78%
Slingshot Bullish Bullish Swing Setup -0.78%
Stochastic Reached Overbought Strength -0.78%
Upper Bollinger Band Walk Strength -0.78%
Wide Bands Range Expansion -0.78%
Overbought Stochastic Strength -0.78%
Older EOD signals for VIE ...
View Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
VIE Chart by TradingView
Basic chart:

Profile

Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.
Medicine Biotechnology Medical Specialties Monoclonal Antibodies Autoimmune And Inflammatory Diseases Humanized Antibody Tolerx Monoclonal Antibody Therapy

Is VIE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 4 Benzinga's Top Upgrades, Downgrades For February 4, 2020
Feb 4 Cantor likes Amicus in premarket analyst action
Jan 16 The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
Jan 15 Viela Bio (VIE) Investor Presentation - Slideshow
Dec 11 Viela Bio initiates mid-stage VIB4920 study
Dec 11 Viela Bio Announces Initiation of Phase 2b Trial of VIB4920 in Sjögren’s Syndrome
Nov 14 VIELA BIO EPS misses by $64.33
Nov 14 Viela Bio Reports Third Quarter 2019 Financial Results and Business Highlights
Nov 12 3 “Strong Buy” Biotech Stocks That Recently Went Public
Oct 28 Sell-siders like Viela Bio in premarket action
See more VIE news...

Indicators

Indicator Value
52 Week High 48.0
52 Week Low 18.2
Average Volume 87,760
200-Day Moving Average 0.00
50-Day Moving Average 34.68
20-Day Moving Average 40.66
10-Day Moving Average 40.77
Average True Range 3.65
ADX 26.16
+DI 33.55
-DI 17.55
Chandelier Exit (Long, 3 ATRs ) 37.04
Chandelier Exit (Short, 3 ATRs ) 44.93
Upper Bollinger Band 47.08
Lower Bollinger Band 34.23
Percent B (%b) 0.8
BandWidth 31.60
MACD Line 2.39
MACD Signal Line 2.05
MACD Histogram 0.3422
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.74
Resistance 3 (R3) 48.77 47.39 48.02
Resistance 2 (R2) 47.39 46.30 47.37 47.78
Resistance 1 (R1) 45.92 45.63 45.23 45.89 47.55
Pivot Point 44.54 44.54 44.19 44.52 44.54
Support 1 (S1) 43.07 43.45 42.38 43.04 41.37
Support 2 (S2) 41.69 42.78 41.67 41.14
Support 3 (S3) 40.22 41.69 40.90
Support 4 (S4) 40.19